P

Protagonist Therapeutics
D

PTGX

38.720
USD
0.20
(0.52%)
مغلق
حجم التداول
24,953
الربح لكل سهم
-0
العائد الربحي
-
P/E
14
حجم السوق
2,307,635,257
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AKRO
    1.240
    (2.45%)
    51.840 USD
    AZN
    AZN
    -0.350
    (-0.47%)
    74.220 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    C
    CRVS
    -0.22000
    (-4.99%)
    4.19000 USD
    G
    G
    -1.240
    (-2.28%)
    53.230 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    K
    KYMR
    -0.650
    (-1.74%)
    36.790 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    المزيد
الأخبار
المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.